Victory Capital Management
AMLX icon

Victory Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Victory Capital Management’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192K Buy
10,707
+63
+0.6% +$974 ﹤0.01% 2272
2026
Q1 		$148K Buy
10,644
+92
+0.9% +$1.29K ﹤0.01% 2235
2025
Q4 		$127K Buy
+10,552
New +$143K ﹤0.01% 2254
2024
Q2 		– Sell
-13,514
Closed -$38.4K – 2475
2024
Q1 		$38.4K Buy
+13,514
New +$177K ﹤0.01% 2396

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Victory Capital Management's AMLX Position: Q2 2026 in Review

Victory Capital Management increased its Amylyx Pharmaceuticals (AMLX) stake by 0.59% in Q2 2026, buying an estimated $974 and bringing the position to 10,707 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #2272.

Victory Capital Management first reported a position in AMLX in Q1 2024 and has held it in 4 quarters since. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Victory Capital Management held 10,707 shares of Amylyx Pharmaceuticals worth $192K as of Q2 2026.
  • Victory Capital Management bought 63 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $974.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2272 holding.
  • Victory Capital Management first reported a position in Amylyx Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.